ITEM VIEW

Application of evidence on probiotics, prebiotics and synbiotics by food industry : a descriptive study

dc.contributor.authorMugambi, Mary N.
dc.contributor.authorYoung, Taryn
dc.contributor.authorBlaauw, Renee
dc.contributor.otherFaculty of Medicine and Health Sciences. Dept. of Interdisciplinary Health Sciences. Human Nutrition.en
dc.date.accessioned2015-04-24T10:06:42Z
dc.date.available2015-04-24T10:06:42Z
dc.date.issued2014-10
dc.identifier.citationMugambi, M.N., et.al. 2014. Application of evidence on probiotics, prebiotics and synbiotics by food industry: a descriptive study. BMC Medical Education, 7(754):1-8. doi:10.1186/1756-0500-7-754.en_ZA
dc.identifier.issn1472-6920 (Online)
dc.identifier.urihttp://hdl.handle.net/10019.1/96492
dc.descriptionThe original publication is available at: http://www.biomedcentral.com/1472-6920/14/228en_ZA
dc.descriptionMugambi, M.N., et.al. 2014. Application of evidence on probiotics, prebiotics and synbiotics by food industry: a descriptive study. BMC Medical Education, 7(754):1-8. doi:10.1186/1756-0500-7-754.en_ZA
dc.descriptionPublication of this article was funded by the Stellenbosch University Open Access Fund.
dc.description.abstractENGLISH ABSTRACT: This study assessed how the food industry applies the knowledge and evidence gained from synbiotics, probiotics or prebiotics research in infants, on the general paediatric population. This study also explored: what happens after the clinical trials using infant formula are completed, data is published or remains unpublished; the effectiveness and type of medium the formula manufacturers use to educate consumers on probiotic, prebiotic or synbiotic infant formula. Findings: This was a descriptive study (a survey) that used a structured questionnaire. All listed companies that manufacture and / or market food products with added probiotics, prebiotics or synbiotics for infants were identified and invited to participate. People responsible for research and development were invited to participate in the survey. A letter of invitation was sent to selected participants and if they expressed willingness to take part in the study, a questionnaire with a written consent form was sent. Descriptive statistics and associations between categorical variables were to be tested using a Chi-square test, a p < 0.05 was statistically significant. A total of 25 major infant formulas, baby food manufacturers were identified, invited to participate in the survey. No company was willing to participate in the survey for different reasons: failure to take any action 5 (20%), decision to participate indefinitely delayed 2 (8%), sensitivity of requested information 3 (12%), company does not conduct clinical trials 1 (4%), company declined without further information 4 (16%), erroneous contact information 6 (24%), refusal by receptionists to forward telephone calls to appropriate staff 3 (12%), language barrier 3 (12%), company no longer agrees to market research 1 (4%). Conclusion: Due to a poor response rate in this study, no conclusion could be drawn on how the food industry applies evidence gained through probiotics, prebiotics or synbiotics research on infants for the benefit of the general paediatric population. More information and greater transparency is needed from the infant formula manufacturers on how they apply the evidence gained from the research on probiotics, prebiotics and synbiotics on infantsen
dc.format.extent8 p.
dc.language.isoen_ZAen
dc.publisherLondon : Biomed Centralen_ZA
dc.subjectFood industryen
dc.subjectInfant formulaen
dc.subjectProbioticsen
dc.subjectPrebioticsen
dc.subjectSynbioticsen
dc.subjectInfant formula industryen_ZA
dc.titleApplication of evidence on probiotics, prebiotics and synbiotics by food industry : a descriptive studyen
dc.typeArticleen
dc.rights.holderAuthors retain copyright


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

ITEM VIEW